20 COMMERCE DRIVE, SUITE 135, CRANFORD, NJ
Market cap: $4.8M (2/09/2026)
Price: $0.06
Stockholder Approval for Reverse Stock Split and Merger Agreement
Seventh Amendment to Section 382 Rights Agreement Executed by Enzon Pharmaceu...
Enzon Pharmaceuticals Enters Sixth Amendment to Section 382 Rights Agreement
Announce Amendment to Merger Agreement
Securities Holder Rights or Indentures, News
Enter into Merger Agreement
News, Securities Holder Rights or Indentures
Material disclosure
Q3
Q1
Amended Annual Report
FY 2023
Q2
FY 2023 amended
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
SC TO-I
Prospectus filed pursuant to Rule 424(b)(3)
S-4
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
Amended Registration of Securities under Section 12(g)